SIC 2834 – Pharmaceutical Preparations
Valuation | |
---|---|
Market Cap ($M) | 797.33 |
Enterprise Value ($M) | 766.28 |
Book Value ($M) | 121.68 |
Book Value / Share | 1.30 |
Price / Book | 6.55 |
NCAV ($M) | 111.62 |
NCAV / Share | 1.19 |
Price / NCAV | 7.14 |
Profitability (mra) | |
---|---|
Return on Invested Capital (ROIC) | -0.72 |
Return on Assets (ROA) | -0.46 |
Return on Equity (ROE) | -0.51 |
Liquidity (mrq) | |
---|---|
Quick Ratio | 5.70 |
Current Ratio | 5.70 |
Balance Sheet (mrq) ($M) | |
---|---|
Current Assets | 135.95 |
Assets | 146.01 |
Liabilities | 24.33 |
Debt | n/a |
Equity | n/a |
Income Statement (mra) ($M) | |
---|---|
Revenue | 0.21 |
Operating Income | -96.57 |
Net Income | -88.39 |
Earnings Per Share Basic And Diluted | n/a |
Earnings Per Share Diluted | n/a |
Earnings Per Share Basic | n/a |
Cash Flow Statement (mra) ($M) | |
---|---|
Cash From Operations | -74.98 |
Cash from Investing | 71.32 |
Cash from Financing | 7.05 |
(click for more detail) |
Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
---|---|---|---|---|
(click for more detail) |
Date | Insider Trades | Code | Shares | Value |
---|---|---|---|---|
(click for more detail) |
File Date | Form | SEC Filings |
---|---|---|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 Form 10-K | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
(click for more detail) |
Short Volume | |||
---|---|---|---|
Market Date | Short Volume | Total Volume | Short Volume Ratio |
83,772 | 1,282,896 | 6.53 | |
177,587 | 1,653,963 | 10.74 | |
545,772 | 1,754,280 | 31.11 | |
142,116 | 743,004 | 19.13 | |
(click for more detail) |
Similar Companies | |
---|---|
CHRS – Coherus BioSciences, Inc. | CLSD – Clearside Biomedical, Inc. |
CLYM – Climb Bio, Inc. | CRMD – CorMedix Inc. |
CRON – Cronos Group Inc. |
Financial data and stock pages provided by
Fintel.io